All Updates

All Updates

icon
Filter
Funding
Metabolon raises USD 60 million in debt financing to strengthen R&D capabilities and enhance metabolomics platform
Precision Medicine
May 16, 2024
This week:
Funding
VR therapy platform CUREosity raises EUR 3.8 million in funding to expand market presence
Extended Reality
Yesterday
Last week:
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Decentralized Finance (DeFi)
Jun 22, 2024
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Web3 Ecosystem
Jun 22, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Data Infrastructure & Analytics
Jun 21, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Foundation Models
Jun 21, 2024
Partnerships
Product updates
Anthropic releases Claude 3.5 Sonnet, the first model in the 3.5 series
Foundation Models
Jun 21, 2024
Funding
Paramount Planet Product raises USD 1 million in federal grant funding to support commercialization
Bio-based Materials
Jun 21, 2024
Regulation/policy
Apple delays launch of Apple Intelligence features in EU citing regulatory concerns
Generative AI Applications
Jun 21, 2024
Product updates
Amazon expands GenAI listing tools to support SMEs
Generative AI Applications
Jun 21, 2024
Funding
Inobat secures EUR 20 million in Series C funding
EV Economy
Jun 21, 2024
Precision Medicine

Precision Medicine

May 16, 2024

Metabolon raises USD 60 million in debt financing to strengthen R&D capabilities and enhance metabolomics platform

Funding

  • Metabolon announced the closing of a USD 60 million credit facility led by Trinity Capital. An initial payment of USD 42.5 million was made at the point of closing the round. The recent round came shortly after a previous equity financing of USD 25 million in January 2023.

  • The company aims to use the newly acquired funds to strengthen its R&D capabilities and enhance its metabolomics platform. It also plans to use the investment for global expansion, including entering new markets and forming strategic partnerships.

  • Metabolomics service provider Metabolon specializes in delivering biochemical data and insights that are helpful in various scientific and clinical inquiries. Its proprietary Metabolon Discover global discovery panel can reportedly detect and identify 5,400+ metabolites within any biological sample through its metabolite library, claimed to be the largest in the industry. Its key biopharma services include biomarker discovery, target identification, pharmacokinetics, and growth media analysis.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.